- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 407/12
Total number of patents in this class: 1443
10-year publication summary
|
112
|
119
|
94
|
105
|
109
|
134
|
73
|
105
|
92
|
25
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
38 |
| Duk San Neolux Co., Ltd. | 512 |
29 |
| Boehringer Ingelheim International GmbH | 4629 |
26 |
| Merck Patent GmbH | 5909 |
26 |
| Takeda Pharmaceutical Company Limited | 2961 |
24 |
| F. Hoffmann-La Roche AG | 7958 |
21 |
| LG Chem, Ltd. | 17205 |
18 |
| LT Materials Co., Ltd. | 312 |
18 |
| Syngenta Participations AG | 4970 |
17 |
| Vertex Pharmaceuticals Incorporated | 1581 |
16 |
| Janssen Pharmaceutica N.V. | 3839 |
14 |
| Samsung Display Co., Ltd. | 30585 |
13 |
| BASF SE | 19740 |
13 |
| Abbvie Inc. | 1808 |
13 |
| Ono Pharmaceutical Co., Ltd. | 454 |
13 |
| Idemitsu Kosan Co., Ltd. | 3995 |
12 |
| Epizyme, Inc. | 383 |
12 |
| Genentech, Inc. | 3742 |
11 |
| Bayer Schering Pharma AG | 460 |
11 |
| Celgene Corporation | 1412 |
11 |
| Other owners | 1087 |